The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection
Clinical trial NCT04766931 · COMPLETED
Trial details
- NCT number
- NCT04766931
- Sponsor
- Frontier Biotechnologies Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2022-08-12
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.